Cyclophosphamide. Cyclophosphamide (Cytoxan), an immunosuppressive agent, may be effective for preventing lung deterioration and is the important agent for treating pulmonary fibrosis. Cyclophosphamide, available in forms that are intravenous and taken by mouth, blocks some of the destructive actions of scleroderma in the lung. Intravenous cyclophosphamide can be life-saving for patients with pneumonia resulting from interstitial lung disease. Si...
Read more »...dermatomyositis, sarcoidosis, as well as other long-standing lung diseases. According to... Read more »
...this diagnosis if there are other problems such as lung disease (asthma, emphysema) present. ... Read more »
...similar drug for a disease processother than ED, namely pulmonary hypertension without untoward... Read more »
An alarming study appearing in the Journal of the American Medical Association suggests that three... Read more »
...was later associated with heart valve defects and pulmonary hypertension and was taken off the... Read more »
TORONTO, Canada (Ivanhoe Broadcast News) About 20 percent of people who need a lung transplant will die waiting for one. Unlike damaged kidneys or... Read summary »
Cleveland Clinic researchers have found that low levels of antioxidants in the cells that line the blood vessels of the lungs may contribute to... Read summary »
A readers who suffers from pulmonary hypertension asks if a stem cell therapy available in the Dominican Republic could help treat her condition. Dr.... Read summary »
The U.S. Food and Drug Administration (FDA) has approved a new drug for pulmonary hypertension. The drug, which will be sold under the brandname... Read summary »
NASHVILLE (Ivanhoe Broadcast News) -- Marilyn Cohn was shocked when her doctor told her what was in the cards. "He said, I had lung cancer, and... Read summary »